Navigation Links
Proton Therapy Carries Precise, Potent Punch Against Cancers for Patients at The Children's Hospital of Philadelphia

Highly Focused Energy Beam Adds Much-Needed Weapon in Treating Brain Tumors, with Gentler Side Effects.

(PRWEB) May 26, 2010 -- The Children’s Hospital of Philadelphia announces the availability of proton therapy, a precise form of cancer radiation that offers potentially life-changing benefits to children with brain tumors and other solid tumors. The Hospital’s Cancer Center has recently begun using proton therapy treatment at the new Roberts Proton Therapy Center, a cutting-edge radiation oncology facility located across the street from Children’s Hospital in Penn Medicine’s Perelman Center for Advanced Medicine.

With a child diagnosed with a brain tumor, parents often face a cruel dilemma. Conventional radiation treatment that offers survival often risks severe side effects, including damage to surrounding healthy tissue, as well as impairments to hearing, vision, growth and cognition. The after-effects may impede a child’s daily life and may carry the prospect of lifelong disability and dependence. In fact, the side effects are potentially devastating enough that conventional radiation therapy is not given to children under age two.

The Roberts Proton Therapy Center is the only proton therapy facility in the country conceived with pediatric patients in mind from the earliest planning stages. Children who receive proton therapy in this $140 million state-of-the-art facility benefit from a long-standing collaboration between Children’s Hospital and radiation oncologists at Penn Medicine. Young proton therapy patients experience family-focused pediatric care from a medical team who understands the unique needs of children with cancer, while providing emotional support for the entire family. Every detail has been considered-- from scheduling morning treatments for children who cannot eat prior to anesthesia, to offering a dedicated child-oriented waiting room and a dedicated pediatric anesthesia room.

“When the Roberts Proton Therapy Center’s pediatric program is fully operational, the Cancer Center at Children’s Hospital will be able to treat more children with proton therapy than all other American proton therapy centers combined, thereby reducing the negative impact of cancer therapy for children from the Philadelphia region and around the country” said John M. Maris, M.D., chief of Oncology and director of the Cancer Center at The Children’s Hospital of Philadelphia.

With its extensive program of comprehensive services, the Cancer Center is one of the largest pediatric cancer programs in the United States. All cancer care is available at one location, including doctor’s visits, lab work and a full range of therapies. In its most recent listings, U.S. News & World Report ranked Children’s Hospital first in cancer care among America’s children’s hospitals.

In addition to its application for brain tumors, proton therapy may also be appropriate for cancers of the head and neck, and tumors located near the spinal cord, heart and lungs—sites perilously close to vital organs.

The advent of proton therapy provides a dramatic reduction in side effects when compared to conventional radiation. Because protons can be more precisely aimed and concentrated on a tumor, much less energy impacts normal tissue in front of and behind the cancerous mass. At the same time, doctors may increase the radiation dose focused on the tumor for optimum benefits.

Protons are positively charged particles, found in the nucleus of every atom, but made available in this therapy by stripping away electrons from hydrogen atoms. Although commonly manipulated by physicists in high-energy particle accelerators in research settings since the mid-20th century, protons are only gradually becoming part of medical practice. There are currently only seven proton therapy centers in the United States.

About The Children’s Hospital of Philadelphia: The Children’s Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country, ranking second in National Institutes of Health funding. In addition, its unique family-centered care and public service programs have brought the 460-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit

Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $3.6 billion enterprise.
Penn’s School of Medicine is currently ranked #2 in U.S. News & World Report’s survey of research-oriented medical schools, and is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $367.2 million awarded in the 2008 fiscal year.

This will be omitted from the actual release, but contact info will be included on the page. ( PRWEB has it’s on contact information section) Note to reporters: For further information, including interviews with Children’s Hospital caregivers and with families of children receiving proton therapy, contact Rachel Salis-Silverman at 267-426-6063


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Northern Illinois Proton Center on the Verge of Major Medical Breakthrough
2. Proton beam therapy shows encouraging long-term outcome for patients with locally advanced sinonasal cancers
3. Patients Who Take a Proton-Pump Inhibitor With Medicine to Prevent Blood Clots Are Less Likely to Be Hospitalized for Bleeding Ulcers
4. Proton's T-4 Automatic Degausser Receives “Best of FOSE 2010” Award
5. Targeted therapy prolongs life in patients with HER2-positive breast cancer
6. PharmMD Secures Investments to Fund New Opportunities in Medication Therapy Management
7. More smokers kick the habit with extended nicotine patch therapy, Penn research shows
8. Experts Issue Warning on Prostate Hormone Therapy
9. ASGCT: Gene Therapy Shows Promise for Patients with Pompe Disease
10. AAPM statement on quality radiation therapy
11. Congress Urged to Take Immediate Action to Ensure Frail Patients Continue to Receive Critical Therapy Services
Post Your Comments:
Related Image:
Proton Therapy Carries Precise, Potent Punch Against Cancers for Patients at The Children's Hospital of Philadelphia 
(Date:11/30/2015)... Wilmington, DE (PRWEB) , ... November 30, 2015 ... ... a guest lecturer at a University of Delaware Accounting and Management of Information ... accounting software solutions for mid-market businesses. Sommer will speak at before student in ...
(Date:11/30/2015)... ... November 30, 2015 , ... A record crowd gathered at the Pennsylvania ... by the Baruch S. Blumberg Institute. , The institute, which is the research arm ... and biotechnology leaders for the conference, which focused on ways companies can work to ...
(Date:11/30/2015)... ... November 30, 2015 , ... ChiliPad ... looking to maximize recovery through quality sleep. Tim DiFrancesco, training coach for the ... better night’s sleep. ChiliPad precisely regulates the surface temperature of each side of ...
(Date:11/30/2015)... ... November 30, 2015 , ... Dr. Seth D. Margulies ... locations, patients can visit Dr. Margulies to experience the best available orthodontic experience in ... title of "NJ Top Dentist"! , Orthodontics is the branch of dentistry that specializes ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... Control Centers’ National Poison Data System (NPDS) reveals that in 2014, someone called ... million cases, over two million of which were human exposure cases. , The ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... 30, 2015  Hanger, Inc. (NYSE: HGR ) ... the terms of its previously announced consent solicitation (as ... $200,000,000 aggregate principal amount 7⅛% Senior Notes due 2018 ... consent fees payable pursuant to the Consent Solicitation, (ii) ... (iii) the expiration date of the Consent Solicitation.    ...
(Date:11/30/2015)... , Belgium , Nov. 30, 2015 ... sciences company focused on developing blood-based diagnostic tests for a ... the Company will present at the LD Micro Conference, which ... Los Angeles, CA. Attending from VolitionRx will be ... Scott Powell , Vice President of Investor Relations. ...
(Date:11/30/2015)... BOSTON , November 30, 2015 /PRNewswire/ ... potential new medicines directed at up to 10 G ... --> PFE ) to research and develop potential ... receptor (GPCR) targets across multiple therapeutic areas. --> ... discovery and development company and wholly-owned subsidiary of Sosei ...
Breaking Medicine Technology: